Pressure BioSciences, Inc. (PBIO) Corporate Media Kit

Patented Process for Disaggregation and Controlled Refolding of Proteins • Most New Drugs are Biological not Chemical • Over 200 Protein Drugs on Market – Many Additional Protein Drugs in Development • Proteins Can Aggregate and Misfold in Manufacturing: Critical Issue • Pressure (BaroFold Platform) Can Disaggregate and Refold Proteins: Addresses Critical Issue • Improves Quality of Protein Drugs and Reduces Cost of Manufacturing • Potential for Millions of Dollars in Annual Revenue from Biotherapeutic Company Licenses • BaroFold Technology Works Well on PBI Instruments (R&D) • Expect Increase in PBI Instrument Sales from Companies Developing Protein-based Drugs VALUE PROPOSITION: BAROFOLD PLATFORM 15